Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Response Genetics Performing MAGE-A3 Screens for Late-Stage GSK Lung Cancer Rx

Response Genetics Performing MAGE-A3 Screens for Late-Stage GSK Lung Cancer Rx

Jan 30, 2008
Premium
Response Genetics announced this week that it has begun gene-expression screening studies for a Phase III trial of GlaxoSmithKline's investigational MAGE-A3 antigen-specific immunotherapeutic for non-small cell lung cancer.
 
GSK is studying the drug as an adjuvant therapy in MAGE-A3-positive patients with stage IB, II, or IIIA NSCLC. Approximately 35 percent to 50 percent of early NSCLC patients express the MAGE-A3 tumor-specific antigen.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

EUA Now Sought

Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Former Minister's Paper Retracted

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

Mink Cull and a Prime Minister

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

Science Presents Prize Winner for Single-Cell Genomic Methods, Study of Erlotinib Insensitivity in Triple-Negative Breast Cancer

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
02
Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.